Pramipexole dihydrochloridis Monohydratorum CAS 191217-81-9 Intende 98.0~ 102.0%

Description:

Pramipexole dihydrochloride Monohydrate

Synonyma: Pramipexole DiHCL Monohydratus

CAS: 191217-81-9

Pertentare: 98.0~ 102.0%

Aspectus: Alba ad Off-White pulveris

Contactus: Dr

Mobile/Wechat/Whatsapp: +86-15026746401

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Descriptio:

Ruifu Chemicum est opificem Pramipexole dihydrochloridis Monohydratorum principalem (CAS: 191217-81-9) cum qualitate alta.Ruifu Chemical traditio totius terrarum, quantitatis competitive pretium, optimum servitium, parvas et moles in promptu habere potest.Purchase Pramipexole dihydrochloridis Monohydratorum,Please contact: alvin@ruifuchem.com

Chemical Properties:

Nomen chemicum Pramipexole dihydrochloride Monohydrate
Synonyma Pramipexole DiHCL Monohydrate;Pramipexole 2HCl Monohydrate;(S) -2-Amino-4,5,6,7-Tetrahydro-6-(Propylamino) benzothiazole dihydrochloride Monohydratum
Stock Status In Stock, Commercial Productio
CAS Number 191217-81-9
Related CAS 104632-25-9 & 104632-26-0
Formulae hypotheticae C10H17N3S·2HCl·H2O
M. Pondus 302.26 g/mol
Liquescens punctum 290℃(dec.)
Imprimis Rotationes [a]20/D -65.0° ad -71.0° (C=1 in MeOH) (calcd.on anh.substance)
Aqua Solubility Solutum in aqua
Solubilitas Solutum in Methanol.Leviter Ethanol.Insolubilis in Dichloromethane
COA & MSDS Praesto
Origin Shanghai, China
Brand Ruifu Chemical

Specifications:

Items Specifications Proventus
Aspectus Alba ad Off-White pulveris Alba pulveris
Temptare (per HPLC) 98.0~ 102.0% 99.34%
Aquae Caroli Fischer 4.5~6.5% Obsequitur
Residere in Ignition ≤0.10% <0.10%
Metalla gravia (Pb) ≤10ppm <10ppm
Pramipexole Propionamidea ≤0.15% Obsequitur
Pramipexole Related Compone A ≤0.15% Obsequitur
N-Propylpramipexole ≤0.15% Obsequitur
Pramipexole Dimer ≤0.15% Obsequitur
Alia individua immunditia ≤0.10% Obsequitur
Puritas Enantiomeric ≤1.00% Obsequitur
Palladium ≤5ppm <5ppm
Infrared Imaginis Congruunt Structure Obsequitur
1H NMR Imaginum Congruunt Structure Obsequitur
conclusio Productum probatum est et cum datis specificationibus obsequitur

Sarcina / at /naviportans:

Sarcina:Fluorinated Utrem, aluminium ffoyle, 25kg/cardboard Drum, vel secundum exigentiam emptoris.
Repono Condition:Continentem arcte clausam et in loco frigido, sicco (2~8℃) reponunt et a cellis bene ventilatis ab substantiis incompossibilibus.A luce et humore protege.
Naviportans:Libera ad mundum ab aere, per FedEx / DHL Express.Ieiunium et certas traditiones provide.

Test Methodi:

C10H17N3S·2HCl·H2O 302.26
(S)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole dihydrochloride monohydrato [191217-81-9].
DEFINITIO
Pramipexolum dihydrochloridum NLT 98.0% continet et NMT 102.0% C10H19Cl2N3S, in fundamento anhydroso computatum.
IDENTIFICATIO
• A. Absorptio infrared <197A> seu <197M>
Undo numerus ambitus: <197A>, 3800 cm-1 ad 650 cm-1;<197M>, 4000 cm-1 ad 600 cm-1
• B. Retentionis tempus solutionis maioris cacuminis in Sample solutioni respondet pramipexoli (S-enantiomer) in solutione idoneitatis systematis in probatione puritatis Enantiomeric.
• C. sativum Testi-generalis, Chloride <191>
Sample: 1 mg/mL Pramipexole dihydrochloridis in aqua
Acceptatio criteria: Nitrata argenti probatio praepropera occurrit
TEMPTATIO
• De modo procedendi
Solutio A: solve 9.1 g phosphas potassii dihydrogenis et 5.0 g monohydratorum natrii 1-octanesulfonatis in 1 L aquae.Acidum phosphoricum ad pH 3.0 compone.
Solutio B: Acetonitrile et Solutio A (1. 1).
Diluent: Acetonitrile et Solutio A (1:4).
Mobile tempus: Vide infra mensam gradientem.
Solutio tempus (min) Solutio A (%) Solutio B (%)
0 60 40
15 20 80
15.1 60 40
20 60 40
Solutio aptabilitas systematis: 1.5 mg/mL USP Pramipexoli dihydrochloridis RS et 0,8 mg/mL of USP Pramipexole Related Compone A RS in Diluent
Solutio Standard: 1.5 mg/mL USP Pramipexoli dihydrochloridis RS in Diluent
Sample solutio: 1.5 mg/mL Pramipexoli dihydrochloridis in diluentia
Systema chromatographicum
(Vide Chromatographiam <621>, Ratio idoneitatis.)
Modus: LC
Detector: UV 264 nm
Columna: 4.6-mm × 15-cm;5-µm stipare L1
columna temperatura: 40 ± 5
Fluunt rate: 1.5 mL/min
Iniectio amplitudo: 5 µL
Ratio convenientia
Exempla: Ratio idoneitatis solutionis solutionis Standardi [Nota-retentionis relativa tempora pro pramipexole affinis compositi A et pramipexoli sunt circiter 0.7 et 1.0, respective.]
Convenientia requisita
Resolutio: NLT 6.0 inter pramipexolum compositum A et pramipexolum relatum, solutio ratio convenientiae
Tailing factor: NMT 2.0 pro pramipexole, ratio solutionis idoneitatis
Vexillum relativum declinationis: NMT 1.0%, Standard solution
Analysis
Exempla: Standard solution et Sample solutionem
Calculare recipis C10H19Cl2N3S in portione Pramipexoli dihydrochloridis sumpti;
Proventus = (rU/rS) (CS/CU) (Mr1/Mr2) 100
rU = apicem responsio ex Sample solutione
rS = apicem responsio ex solutione Latin
CS = intentio USP Pramipexole dihydrochloride RS in solutione Standard (mg/mL)
CU = retrahitur Sample solutionis (mg/mL)
Mr1 = pondus hypotheticum pramipexoli dihydrochloridis, 284.26
Mr2 = pondus hypotheticum monohydratorum pramipexoli dihydrochloridis, 302,26
Acceptatio criteria: 98.0% -102.0% in anhydrous basis
IMPURITIES
Inorganic immunditias
• Residuum in Ignitione <281>: NMT 0.10%
• Metalla gravia, Methodus I <231>
Solutio Standard: Solutio in Latin Duc, 10 ppm
Sample solutio: Cinerum 2 g Pramipexoli dihydrochloridis usque dum massam carbonised paene aridam obtinet.Residuum refrigerant, adde acidi nitrici concentrati 2.0 mL et 5 guttas acidi sulphurici concentrati, et fumos diligenter evolvere permittunt.D-600 accende donec carbonis totaliter exuratur.Residuum refrigerant, addunt 4 mL acidum hydrochlorici 6 M, testae tegunt, et in aqua ferventi lavacrum 15 min concoquunt.Exalat ad siccitatem.Adde unam guttam acidi hydrochlorici concentrati et 10 mL aquae calidae, et plura 2 min in balneum aquae fervidae concoquere.Solutio ammoniaci 6 M guttatim adde donec solutio alcalina sit infirma, et cum 1 M acidum aceticum componas ad pH 3.0-4.0.Solutio sparguntur in lagena voluminis 25-mL, et aqua diluunt ad 25 mL lavando uas et colum.
Acceptatio criteria: NMT 10 ppm
Impurities organica
• De modo procedendi
Solutio A, Solutio B, Diluente, Phase mobile, et systema chromatographicum: Perge ut fertur in primordio.
Solutio aptabilitas systematis: 7.5 µg/mL USP Pramipexoli dihydrochloridis RS et 3 µg/mL USP Pramipexoli Compositae A RS in Diluent.
Solutio Standard: 1.5 μg/mL USP Pramipexoli dihydrochloridis RS in Diluent
Sample solutio: 1.5 mg/mL Pramipexoli dihydrochloridis in diluentia
Ratio convenientia
Exempla: Ratio idoneitatis solutionis et solutionis Standardi
Convenientia requisita
Resolutio: NLT 6.0 inter pramipexolum compositum A et pramipexolum relatum, solutio ratio convenientiae
Tailing factor: NMT 2.0 pro pramipexole, ratio solutionis idoneitatis
Vexillum relativum declinationis: NMT 5.0%, Standard solution
Analysis
Exempla: Standard solution et Sample solutionem
Calculare recipis immunditiam singularem in portione Pramipexoli dihydrochloridis sumptae;
Proventus = (rU/rS) (CS/CU) (Mr1/Mr2) 100
rU = apicem responsionis cuiusque immunditiae ex Sample solutione
rS = apicem responsionis pramipexole ex solutione Standard
CS = intentio USP Pramipexole dihydrochloride RS in solutione Standard (mg/mL)
CU = intentio pramipexoli dihydrochloridis monohydratorum in Sample solutione (mg/mL)
Mr1 = pondus hypotheticum pramipexoli dihydrochloridis, 284.26
Mr2 = pondus hypotheticum monohydratorum pramipexoli dihydrochloridis, 302,26
Criteria acceptatio
Individua Impudicitia: Vide Mensam Impuritas 1 .
Totalis immunditiae: NMT 0.5%
De immunitate Tabula 1
Nomen relativum Retentionis Tempus acceptationis Criteria, NMT (%)
Pramipexole propionamideum 0.5 0.15
Pramipexole affinis compositi Ab 0.7 0.15
Pramipexole 1.0 —
N-Propylpramipexolec 1.4 0.15
Pramipexole dimerd 1.7 0.15
Quaelibet alia individua immunditia unidentificata - 0.10
a (S)-N-(2-Amino-4,5,6,7-tetrahydrobenzothiazol-6-yl)propionamide.
b (S)-4,5,6,7-Tetrahydrobenzothiazole-2,6-diamine.
c (S)-2,6-Dipropylamino-4,5,6,7-tetrahydrobenzothiazole.
d N6,N6'-[2-Methylpentanum-1,3-diyl]bis(4,5,6,7-tetrahydrobenzothiazole-2,6-diamine).Hoc dimer pramipexole est (mistura quatuor isomers fieri).
IN SPECIE TESTS
• Determinatio aquae, Methodus I <921>: NLT 4.5% et NMT 6.5%
• Puritas Enantiomeric
Mobile tempus: n-Hexane, alcohol dehydratum, et diethylamine (850:150:1)
Systema idoneitatem stirpem solutionis: 1 mg/mL singulae USP Pramipexole dihydrochloride RS et USP Pramipexole Compositi D RS in alcohole dehydrato coniuncti.
Solutio aptabilitas systematis: 0.01 mg/mL singulae USP Pramipexole dihydrochloridi RS et USP Pramipexole Composita D RS ex solutione systematis idoneitatis stirpis in tempore Mobili
Standard stock solution: 2.0 mg/mL of USP Pramipexole Related Compone D RS in alcohole siccitatis
Solutio Standard: 1.5 µg/mL of USP Pramipexole Composito D RS in Mobili periodo
Sample solutio: 0,3 mg/mL, praeparata solvendo aptam quantitatem pramipexoli dihydrochloridi ponderatam in 25% voluminis ampullae alcoholi dehydratae et diluentis cum tempore ad volumen mobile.
Systema chromatographicum
(Vide Chromatographia 621, Ratio Suitability).
Modus: LC
Detector: UV 254 nm
Columna: 4.6-mm × 25-cm;10-µm stipare L51
Fluunt rate: 1.5 mL/min
Magnitudo: 75 µL
Ratio convenientia
Exempla: Solutio idoneitatis systematis [Nota-retentio relativa temporum ad pramipexolum compositum D (R-enantiomer) et pramipexolum (S-enantiomer) sunt 0.5 et 1.0, respective.]
Convenientia requisita
Resolutio: NLT 5.0 inter pramipexolum compositum D et pramipexolum relatum, solutio ratio convenientiae
Tailing factor: NMT 2.4 pro pramipexole, ratio solutionis idoneitatis
Analysis
Exempla: Standard solution et Sample solutionem
Calculare recipis pramipexoli compositi D relati in portione Pramipexoli dihydrochloridis sumpti;
Proventus = (rU/rS) (CS/CU) 100
rU = apicem responsionis pramipexoli compositi D relati ex solutione Sample
rS = cacumen responsionis pramipexole affinis compositi D ex solutione Standard
CS = retrahitur pramipexole affinis compositi D in solutione Standard (mg/mL)
CU = retrahitur Sample solutionis (mg/mL)
Criteria acceptationis: NMT 1.0% pramipexoli compositi D . relati
• Palladii modus
[Nota hoc experimentum praestare si Palladium sit notum inorganicae immunditiae.]
Diluent: 0.1 M acidum hydrochloricum
Solutio Standard: 40 µg/L palladii in Diluent, ex commercio solutionis normae Palladii praesto pro effusio atomica / inductive plasma copulatum.Hanc solutionem nuper usui necessariam praeparet.]
Sample solutio: Ad 0.5 g pramipexoli dihydrochloridis in L-mL lagena voluminis 5.00 mL ex 1 M acidum hydrochloricum adde et cum calefactione solvendum.Frigidus est locus temperatus, et aqua diluto ad volumen.
Spectrometric conditiones
(See Spectrophotometry and Light-Scattering 851).
Modus: Effusio atomica spectrophotometry
Analytica necem: Palladium emissio lineae ad 247.6 nm
Lucerna: cavum cathode
Fons atomisationum: Graphite fornax.[Nota—sequere sequentia programmandi artificis commendatur.]
Magnitudo exempli: 20 µL
Blank: Diluent
Ratio convenientia
Sample: Latin solution
Convenientia requisita
Absorbance: NLT 0.034
Analysis
Exempla: Standard solution et Sample solutionem
Determinare intentionem Palladii in Sample solutione per modum normae adiectae.
Acceptatio criteria: NMT 5 ppm
ADDITICIUS REQUISITIS
• Packaging and storage : Conserva in vasis bene clausis , ab humido et lumine munitus .
• USP Reference signa 11
USP Pramipexole Dihydrochloride RS Click to View Structure
USP Pramipexole Related Compone A RS
(S)-4,5,6,7-Tetrahydrobenzothiazole-2,6-diamine.
C7H11N3S 169.25
USP Pramipexole Related Compone D RS
(R) -2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole.
C10H17N3S 211.33

commoda:

Satis capacitas: sufficientes facilities et technici

Professional Service: One stop acquireing service

Altera Package: Custom sarcina ac titulus praesto

Ieiunium Delivery: Si intra stirpem, tres dies partus praestatur

Supple firmum: Esse rationabile stirpe

Technical Support: Technology solution praesto

Custom Synthesis Service: Range from P. to kilos

High Quality: Constitutus ratio completa qualitas certitudinis

FAQ:

Quam mercari?Quaeso contactumDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com 

15 Years Experience?Plus quam XV annos experientiae habemus in fabricando et exportando amplis intermediis pharmaceuticis vel alchimicis pharmaceuticis amplis.

Mercatus principalis?Vendere mercatum domesticum, Americam septentrionalem, Europam, Indiam, Coream, Iaponicam, Australiam etc.

Commodi?Superior qualitas, parabilis pretium, officia professionalia et subsidia technica, ieiunium partus.

Qualitasfides?Qualitas strictioris temperantiae ratio.Pro instrumento analysi professionali includuntur NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Claritas, Solubilitas, Microbialis limes test, etc.

Exempla?Pleraque producta praebent exempla gratuita pro qualitate aestimationis, sumptus naviculas a clientibus solvendos.

Factory Audit?Factory audit gratissimum.Quaeso ante constitutum.

MOQ?Nec MOQ.Parvus ordo placet.

Tempus adferendi? Si intus prosapia, tres dies partus praestatur.

Transportatio?Per Express (FedEx, DHL), ab Air, per Mare.

Documenta?Post servitium venditionis: COA, MOA, ROS, MSDS, etc. praeberi possunt.

Consuetudo Synthesis?Consuetudo synthesis officia praebere potest ad optimas investigationes tuas necessitates aptandas.

Pensio conditio?Proforma cautionis primum post confirmationem ordinis mittetur, informationes nostrae ripae inclusas.Payment by T/T (Telex Transfer), PayPal, Western Union, etc.

63-91-2-Salus Information:

H

Applicatio:

Pramipexole dihydrochloride Monohydratorum (CAS: 191217-81-9) adhibetur

Epistulam tuam hic scribe et mitte nobis